Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients

INTRODUCTION: Previous studies have demonstrated the superior efficacy of a novel aerosol foam formulation of fixed combination calcipotriene 0.005% (Cal) and betamethasone dipropionate 0.064% (BD), compared with the ointment formulation. The aim of this study is to ascertain whether enhanced bioava...

Descripción completa

Detalles Bibliográficos
Autores principales: Lind, Marianne, Nielsen, Kim Troensegaard, Schefe, Line Hollesen, Nørremark, Kasper, Eriksson, André Huss, Norsgaard, Hanne, Pedersen, Brian Thoning, Petersson, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972731/
https://www.ncbi.nlm.nih.gov/pubmed/27358072
http://dx.doi.org/10.1007/s13555-016-0125-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972731/
https://www.ncbi.nlm.nih.gov/pubmed/27358072
http://dx.doi.org/10.1007/s13555-016-0125-6

Ejemplares similares